000 01438 a2200373 4500
005 20250517165117.0
264 0 _c20170816
008 201708s 0 0 eng d
022 _a1097-6744
024 7 _a10.1016/j.ahj.2017.05.009
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSeltzer, Jonathan H
245 0 0 _aUse of endpoint adjudication to improve the quality and validity of endpoint assessment for medical device development and post marketing evaluation: Rationale and best practices. A report from the cardiac safety research consortium.
_h[electronic resource]
260 _bAmerican heart journal
_cAug 2017
300 _a76-85 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aBiomedical Research
650 0 4 _aCardiovascular Diseases
_xtherapy
650 0 4 _aEndpoint Determination
_xstandards
650 0 4 _aEquipment and Supplies
650 0 4 _aHumans
650 0 4 _aProduct Surveillance, Postmarketing
_xmethods
650 0 4 _aUnited States
650 0 4 _aUnited States Food and Drug Administration
700 1 _aHeise, Ted
700 1 _aCarson, Peter
700 1 _aCanos, Daniel
700 1 _aHiatt, Jo Carol
700 1 _aVranckx, Pascal
700 1 _aChristen, Thomas
700 1 _aCutlip, Donald E
773 0 _tAmerican heart journal
_gvol. 190
_gp. 76-85
856 4 0 _uhttps://doi.org/10.1016/j.ahj.2017.05.009
_zAvailable from publisher's website
999 _c27418657
_d27418657